Crossing the Line Between Food and Drugs
This article was originally published in RPM Report
In the era of “nutraceuticals,” the lines between a food, a dietary supplement, a drug can be hard to define—even though they make a huge difference in the regulatory standards that apply. In a March 5 Warning Letter to Breathable Foods Inc., however, the agency drew a very bright line when it comes to inhaled caffeine: the role played by the human epiglottis.
You may also be interested in...
Taiwan’s JHL Biotech has rebranded itself as Eden Biologics at the same time as it has announced progress on clinical trials for its denosumab biosimilar candidate.
Starpharma's COVID-busting Viraleze antiviral nasal spray will soon be available across Europe, included the UK. But will it fall foul of local evidence requirements, for example in France, where the country's medicines agency has halted the sale of Pharma & Beauty (P&B) Group's COV-Defense spray until its efficacy against COVID has been confirmed by human-based studies?
Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization
A round up of COVID-19 developments, also including news on the EMA beginning a rolling review of Celltrion's antibody therapy, and progress for Novavax and Moderna in Japan.